In industry news:

Coventry recently released part three of its Annual Drug Trends Series. In part three of the series Coventry looks at opioids, which continue to decrease in proportion to overall scripts and costs, with favorable trends in Morphine Equivalent Dose (MED), duration of use, and access to guideline-supported measures including Medication-Assisted Treatment (MAT) and overdose rescue medications.

Read more here.

Leave a Comment

Your email address will not be published. Required fields are marked *